Clearbridge Investments, LLC Gilead Sciences, Inc. Transaction History

Clearbridge Investments, LLC

$123 Billion
Q3 2024

A detailed history of Clearbridge Investments, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Clearbridge Investments, LLC holds 5,176,300 shares of GILD stock, worth $479 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares

5,176,300

Previous 4,781,031 8.27%

Holding current value

$479 Million

Previous $328 Million 32.27%

% of portfolio

0.35%

Previous 0.27%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$66.59 - $83.99 $26.3 Million - $33.2 Million	395,269 Added 8.27%	5,176,300 $434 Million
Q2 2024 Aug 14, 2024	SELL	$63.15 - $72.88 $3.57 Million - $4.12 Million	-56,526 Reduced 1.17%	4,781,031 $328 Million
Q1 2024 May 13, 2024	SELL	$71.58 - $87.29 $6.02 Million - $7.34 Million	-84,104 Reduced 1.71%	4,837,557 $354 Million
Q4 2023 Feb 09, 2024	BUY	$73.27 - $83.09 $27.7 Million - $31.4 Million	377,676 Added 8.31%	4,921,661 $399 Million
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $216 Million - $235 Million	2,915,141 Added 178.97%	4,543,985 $341 Million
Q2 2023 Aug 11, 2023	BUY	$76.01 - $86.7 $33.7 Million - $38.4 Million	442,972 Added 37.35%	1,628,844 $126 Million
Q1 2023 May 12, 2023	SELL	$77.31 - $88.08 $503,365 - $573,488	-6,511 Reduced 0.55%	1,185,872 $98.4 Million
Q4 2022 Feb 10, 2023	SELL	$62.32 - $89.47 $20.6 Million - $29.6 Million	-330,741 Reduced 21.71%	1,192,383 $102 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $5.58 Million - $6.37 Million	93,668 Added 6.55%	1,523,124 $94 Million
Q2 2022 Aug 11, 2022	SELL	$57.72 - $65.01 $3.71 Million - $4.18 Million	-64,241 Reduced 4.3%	1,429,456 $88.4 Million
Q1 2022 May 13, 2022	SELL	$57.92 - $72.58 $31.1 Million - $39 Million	-537,540 Reduced 26.46%	1,493,697 $88.8 Million
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $4.46 Million - $5.06 Million	68,690 Added 3.5%	2,031,237 $147 Million
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $9.64 Million - $10.4 Million	142,453 Added 7.83%	1,962,547 $137 Million
Q2 2021 Aug 13, 2021	BUY	$63.47 - $69.35 $6.69 Million - $7.32 Million	105,482 Added 6.15%	1,820,094 $125 Million
Q1 2021 May 13, 2021	BUY	$60.0 - $68.46 $61.7 Million - $70.4 Million	1,028,302 Added 149.83%	1,714,612 $111 Million
Q4 2020 Feb 10, 2021	BUY	$56.65 - $64.55 $10.5 Million - $12 Million	185,217 Added 36.96%	686,310 $40 Million
Q3 2020 Nov 12, 2020	BUY	$62.1 - $78.08 $22.4 Million - $28.2 Million	361,100 Added 257.94%	501,093 $31.7 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $2.69 Million - $3.12 Million	-37,133 Reduced 20.96%	139,993 $10.8 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $37.4 Million - $47.9 Million	-597,246 Reduced 77.13%	177,126 $13.2 Million
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $955,233 - $1.05 Million	-15,502 Reduced 1.96%	774,372 $50.5 Million
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $795,627 - $878,232	-12,728 Reduced 1.59%	789,874 $50.1 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $925,080 - $1.04 Million	-14,952 Reduced 1.83%	802,602 $0
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $46,772 - $52,397	-748 Reduced 0.09%	817,554 $53.1 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $32.3 Million - $42.1 Million	533,033 Added 186.85%	818,302 $51.2 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $8.48 Million - $9.39 Million	-118,919 Reduced 29.42%	285,269 $22 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $21.2 Million - $24.7 Million	326,552 Added 420.62%	404,188 $28.6 Million
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $4.67 Million - $5.69 Million	64,124 Added 474.57%	77,636 $5.85 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $913,708 - $1.07 Million	12,842 Added 1916.72%	13,512 $968,000
Q3 2017 Nov 14, 2017	SELL	$72.11 - $85.47 $10,816 - $12,820	-150 Reduced 18.29%	670 $54,000
Q2 2017 Aug 14, 2017	BUY	N/A	820	820 $58,000

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearbridge Investments, LLC with notifications on news.

Account

Clearbridge Investments, LLC Gilead Sciences, Inc. Transaction History